Literature DB >> 30358897

Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency.

Paola Bianchi1, Elisa Fermo1, Bertil Glader2, Hitoshi Kanno3, Archana Agarwal4, Wilma Barcellini1, Stefan Eber5, James D Hoyer6, David J Kuter7, Tabita Magalhães Maia8, Maria Del Mar Mañu-Pereira9, Theodosia A Kalfa10, Serge Pissard11, José-Carlos Segovia12,13, Eduard van Beers14, Patrick G Gallagher15, David C Rees16, Richard van Wijk17.   

Abstract

Pyruvate kinase deficiency (PKD) is the most common enzyme defect of glycolysis and an important cause of hereditary, nonspherocytic hemolytic anemia. The disease has a worldwide geographical distribution but there are no verified data regarding its frequency. Difficulties in the diagnostic workflow and interpretation of PK enzyme assay likely play a role. By the creation of a global PKD International Working Group in 2016, involving 24 experts from 20 Centers of Expertise we studied the current gaps in the diagnosis of PKD in order to establish diagnostic guidelines. By means of a detailed survey and subsequent discussions, multiple aspects of the diagnosis of PKD were evaluated and discussed by members of Expert Centers from Europe, USA, and Asia directly involved in diagnosis. Broad consensus was reached among the Centers on many clinical and technical aspects of the diagnosis of PKD. The results of this study are here presented as recommendations for the diagnosis of PKD and used to prepare a diagnostic algorithm. This information might be helpful for other Centers to deliver timely and appropriate diagnosis and to increase awareness in PKD.
© 2018 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30358897      PMCID: PMC7344868          DOI: 10.1002/ajh.25325

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  101 in total

1.  Enzymatic diagnosis in non-spherocytic hemolytic anemia.

Authors:  A Hirono; L Forman; E Beutler
Journal:  Medicine (Baltimore)       Date:  1988-03       Impact factor: 1.889

2.  Structural and functional linkages between subunit interfaces in mammalian pyruvate kinase.

Authors:  J O Wooll; R H Friesen; M A White; S J Watowich; R O Fox; J C Lee; E W Czerwinski
Journal:  J Mol Biol       Date:  2001-09-21       Impact factor: 5.469

3.  Congenital dyserythropoietic anemia type II (CDAII) is caused by mutations in the SEC23B gene.

Authors:  Paola Bianchi; Elisa Fermo; Cristina Vercellati; Carla Boschetti; Wilma Barcellini; Alessandra Iurlo; Anna Paola Marcello; Pier Giorgio Righetti; Alberto Zanella
Journal:  Hum Mutat       Date:  2009-09       Impact factor: 4.878

Review 4.  Hemolytic anemia.

Authors:  Gurpreet Dhaliwal; Patricia A Cornett; Lawrence M Tierney
Journal:  Am Fam Physician       Date:  2004-06-01       Impact factor: 3.292

5.  Erythrocyte pyruvate kinase deficiency: relations of residual enzyme activity, altered regulation of defective enzymes and concentrations of high-energy phosphates with the severity of clinical manifestation.

Authors:  M Lakomek; B Neubauer; A von der Lühe; G Hoch; H Winkler; W Schröter
Journal:  Eur J Haematol       Date:  1992-08       Impact factor: 2.997

6.  Pyruvate kinase deficiency associated with severe liver dysfunction in the newborn.

Authors:  Martine F Raphaël; Richard Van Wijk; Joachim J Schweizer; Netteke A Y Schouten-van Meeteren; Angelika Kindermann; Wouter W van Solinge; Frans J Smiers
Journal:  Am J Hematol       Date:  2007-11       Impact factor: 10.047

7.  Detection of new pathogenic mutations in patients with congenital haemolytic anaemia using next-generation sequencing.

Authors:  R Del Orbe Barreto; B Arrizabalaga; A B De la Hoz; Á García-Orad; M I Tejada; J C Garcia-Ruiz; T Fidalgo; C Bento; L Manco; M L Ribeiro
Journal:  Int J Lab Hematol       Date:  2016-07-17       Impact factor: 2.877

8.  A case of hereditary spherocytosis misdiagnosed as pyruvate kinase deficient hemolytic anemia.

Authors:  Cristina Vercellati; Anna Paola Marcello; Elisa Fermo; Wilma Barcellini; Alberto Zanella; Paola Bianchi
Journal:  Clin Lab       Date:  2013       Impact factor: 1.138

9.  Genotype-phenotype correlation and risk stratification in a cohort of 123 hereditary stomatocytosis patients.

Authors:  Immacolata Andolfo; Roberta Russo; Barbara Eleni Rosato; Francesco Manna; Antonella Gambale; Carlo Brugnara; Achille Iolascon
Journal:  Am J Hematol       Date:  2018-10-02       Impact factor: 10.047

10.  The structure of cat muscle pyruvate kinase.

Authors:  H Muirhead; D A Clayden; D Barford; C G Lorimer; L A Fothergill-Gilmore; E Schiltz; W Schmitt
Journal:  EMBO J       Date:  1986-03       Impact factor: 11.598

View more
  16 in total

1.  Compound heterozygosity in PKLR gene for a previously unrecognized intronic polymorphism and a rare missense mutation as a novel cause of severe pyruvate kinase deficiency.

Authors:  Shruti Bagla; Kanta Bhambhani; Manisha Gadgeel; Steven Buck; Jian-Ping Jin; Yaddanapudi Ravindranath
Journal:  Haematologica       Date:  2019-04-04       Impact factor: 9.941

2.  Genotype-phenotype correlation and molecular heterogeneity in pyruvate kinase deficiency.

Authors:  Paola Bianchi; Elisa Fermo; Kimberly Lezon-Geyda; Eduard J van Beers; Holmes D Morton; Wilma Barcellini; Bertil Glader; Satheesh Chonat; Yaddanapudi Ravindranath; Peter E Newburger; Nina Kollmar; Jenny M Despotovic; Madeleine Verhovsek; Mukta Sharma; Janet L Kwiatkowski; Kevin H M Kuo; Marcin W Wlodarski; Hassan M Yaish; Susanne Holzhauer; Heng Wang; Joachim Kunz; Kathryn Addonizio; Hasan Al-Sayegh; Wendy B London; Oliver Andres; Richard van Wijk; Patrick G Gallagher; Rachael F F Grace
Journal:  Am J Hematol       Date:  2020-03-06       Impact factor: 10.047

3.  Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy.

Authors:  Minke A E Rab; Jennifer Bos; Brigitte A van Oirschot; Stephanie van Straaten; Penelope A Kosinski; Victor Chubukov; Hyeryun Kim; Heidi Mangus; Roger E G Schutgens; Gerard Pasterkamp; Lenny Dang; Charles Kung; Eduard J van Beers; Richard van Wijk
Journal:  Blood       Date:  2021-05-27       Impact factor: 22.113

4.  Novel Compound Heterozygous PKLR Mutation Induced Pyruvate Kinase Deficiency With Persistent Pulmonary Hypertension in a Neonate: A Case Report.

Authors:  Sha Lin; Xintian Hua; Jinrong Li; Yifei Li
Journal:  Front Cardiovasc Med       Date:  2022-04-26

5.  Exome sequencing for diagnosis of congenital hemolytic anemia.

Authors:  Lamisse Mansour-Hendili; Abdelrazak Aissat; Bouchra Badaoui; Mehdi Sakka; Christine Gameiro; Valérie Ortonne; Orianne Wagner-Ballon; Serge Pissard; Véronique Picard; Khaldoun Ghazal; Michel Bahuau; Corinne Guitton; Ziad Mansour; Mylène Duplan; Arnaud Petit; Nathalie Costedoat-Chalumeau; Marc Michel; Pablo Bartolucci; Stéphane Moutereau; Benoît Funalot; Frédéric Galactéros
Journal:  Orphanet J Rare Dis       Date:  2020-07-08       Impact factor: 4.123

6.  Prevalence of pyruvate kinase deficiency: A systematic literature review.

Authors:  Matthew H Secrest; Mike Storm; Courtney Carrington; Deborah Casso; Keely Gilroy; Leanne Pladson; Audra N Boscoe
Journal:  Eur J Haematol       Date:  2020-06-23       Impact factor: 2.997

7.  Targeted Next Generation Sequencing and Diagnosis of Congenital Hemolytic Anemias: A Three Years Experience Monocentric Study.

Authors:  Elisa Fermo; Cristina Vercellati; Anna Paola Marcello; Ebru Yilmaz Keskin; Silverio Perrotta; Anna Zaninoni; Valentina Brancaleoni; Alberto Zanella; Juri A Giannotta; Wilma Barcellini; Paola Bianchi
Journal:  Front Physiol       Date:  2021-05-21       Impact factor: 4.566

8.  A Unique Epigenomic Landscape Defines Human Erythropoiesis.

Authors:  Vincent P Schulz; Hongxia Yan; Kimberly Lezon-Geyda; Xiuli An; John Hale; Christopher D Hillyer; Narla Mohandas; Patrick G Gallagher
Journal:  Cell Rep       Date:  2019-09-10       Impact factor: 9.423

Review 9.  Molecular heterogeneity of pyruvate kinase deficiency.

Authors:  Paola Bianchi; Elisa Fermo
Journal:  Haematologica       Date:  2020-09-01       Impact factor: 9.941

10.  The variable manifestations of disease in pyruvate kinase deficiency and their management.

Authors:  Hanny Al-Samkari; Eduard J Van Beers; Kevin H M Kuo; Wilma Barcellini; Paola Bianchi; Andreas Glenthøj; María Del Mar Mañú Pereira; Richard Van Wijk; Bertil Glader; Rachael F Grace
Journal:  Haematologica       Date:  2020-09-01       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.